Skip to main content
. 2019 Mar 15;26(7):2210–2221. doi: 10.1245/s10434-019-07294-y

Fig. 3.

Fig. 3

Disease-free survival of patients with synchronous versus metachronous colorectal peritoneal metastases who underwent CRS with HIPEC